Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER J BETTACCHI

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1083669543
CMS profile
230546
Location
MARION, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$49,665.94

148 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
ViiV Healthcare Company $47,035.68 96
Merck Sharp & Dohme LLC $1,258.79 11
Gilead Sciences, Inc. $737.79 13
Insmed, Inc. $188.36 7
Astellas Pharma US Inc $88.66 4
Shionogi Inc $81.09 5
ABBVIE INC. $77.46 3
PFIZER INC. $74.45 3
Paratek Pharmaceuticals, Inc. $34.93 2
Theratechnologies Inc. $30.58 1
Octapharma USA, Inc. $21.95 1
La Jolla Pharmaceutical Company $19.67 1
HOSPIRA, INC. $16.53 1

Page 3 of 3; records 101–148 of 148 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER J BETTACCHI

NPI 1083669543 · CMS profile ID 230546

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

MARION, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–148 of 148 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083669543?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER J BETTACCHI, NPI 1083669543, CMS profile ID 230546. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–148 of 148 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083669543?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). CHRISTOPHER J BETTACCHI, NPI 1083669543, CMS profile ID 230546. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–148 of 148 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083669543?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
CHRISTOPHER J BETTACCHI, NPI 1083669543, CMS profile ID 230546, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–148 of 148 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1083669543?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

148 matching records · $49,665.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 148 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–148 of 148.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ViiV Healthcare Company $29.8204/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189600972 CMS
Octapharma USA, Inc. $21.9504/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245075409 CMS
ViiV Healthcare Company $28.4004/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189542101 CMS
ViiV Healthcare Company $116.7304/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189628043 CMS
Astellas Pharma US Inc $25.4704/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238778142 CMS
Gilead Sciences, Inc. $141.4204/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234377522 CMS
Shionogi Inc $13.9604/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250720981 CMS
ViiV Healthcare Company $99.7504/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189529292 CMS
ViiV Healthcare Company $828.6004/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189549389 CMS
ViiV Healthcare Company $24.8504/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189585859 CMS
ViiV Healthcare Company $2,600.0004/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189598738 CMS
ViiV Healthcare Company $7,150.0003/28/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189580638 CMS
ABBVIE INC. $21.1203/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201510650 CMS
ViiV Healthcare Company $23.1603/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189611019 CMS
ViiV Healthcare Company $1,300.0003/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189512752 CMS
ViiV Healthcare Company $172.5503/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189575836 CMS
ViiV Healthcare Company $2,600.0003/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189608701 CMS
Merck Sharp & Dohme LLC $26.0003/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238272044 CMS
Gilead Sciences, Inc. $123.8603/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234386046 CMS
ViiV Healthcare Company $94.0503/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189626099 CMS
ViiV Healthcare Company $125.2303/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189559712 CMS
ViiV Healthcare Company $31.7103/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189618724 CMS
ViiV Healthcare Company $113.6903/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189513384 CMS
ViiV Healthcare Company $106.2403/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189517982 CMS
ViiV Healthcare Company $22.0803/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189540789 CMS
ViiV Healthcare Company $92.2903/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189585639 CMS
ViiV Healthcare Company $472.3403/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189587627 CMS
ViiV Healthcare Company $22.0803/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189598182 CMS
Astellas Pharma US Inc $19.4302/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238753162 CMS
ViiV Healthcare Company $65.8802/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189605695 CMS
ViiV Healthcare Company $124.3902/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189615228 CMS
ViiV Healthcare Company $47.6002/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189621328 CMS
Insmed, Inc. $26.1802/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186294685 CMS
ViiV Healthcare Company $31.0802/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189540229 CMS
ABBVIE INC. $31.8402/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201510648 CMS
Gilead Sciences, Inc. $23.3802/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234490606 CMS
ViiV Healthcare Company $123.6502/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189574821 CMS
Insmed, Inc. $25.2802/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186294397 CMS
ViiV Healthcare Company $32.5902/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189609651 CMS
ViiV Healthcare Company $24.3501/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189587161 CMS
Astellas Pharma US Inc $22.5501/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238728122 CMS
ViiV Healthcare Company $30.0801/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189510116 CMS
ViiV Healthcare Company $114.7501/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189608873 CMS
ViiV Healthcare Company $41.7901/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189560714 CMS
ViiV Healthcare Company $717.8801/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189575316 CMS
ViiV Healthcare Company $24.2901/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189623808 CMS
Merck Sharp & Dohme LLC $22.4201/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238272046 CMS
Shionogi Inc $17.3801/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250720961 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,552.08 129
PY2020 $6,102.36 53
PY2021 $10,808.69 61
PY2022 $50,197.42 153
PY2023 $65,822.95 188
PY2024 $46,028.40 146
PY2025 $49,665.94 148

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $324,625.63 26
PY2024 Principal investigator $938,276.52 60
PY2023 Recipient $2,432.17 20
PY2023 Principal investigator $693,798.36 90
PY2022 Principal investigator $609,614.58 83
PY2021 Principal investigator $1,531,977.61 52
PY2020 Principal investigator $942,119.49 228
PY2019 Principal investigator $531,393.95 106

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $1,584.30 12/31/2025 Non-covered Recipient Entity
North Texas Infectious Diseases Consultants, P.A
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV No dispute reported 06/30/2026 1232933876
Principal investigator 1 ViiV Healthcare Company $21,488.25 11/19/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317241
Principal investigator 1 ABBVIE INC. $1,130.99 11/04/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202521077
Principal investigator 1 ViiV Healthcare Company $24,949.53 10/28/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319205
Principal investigator 1 ViiV Healthcare Company $16,297.36 09/23/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317239
Principal investigator 1 ViiV Healthcare Company $3,187.08 09/19/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317181
Principal investigator 1 ViiV Healthcare Company $7,334.74 08/29/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190319209
Principal investigator 1 ViiV Healthcare Company $32,732.88 08/15/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317237
Principal investigator 1 ABBVIE INC. $1,382.40 08/05/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202501142
Principal investigator 1 ViiV Healthcare Company $7,502.34 07/23/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317177
Principal investigator 1 ViiV Healthcare Company $25,220.75 07/17/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317229
Principal investigator 1 ViiV Healthcare Company $3,187.08 06/13/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317179
Principal investigator 1 ViiV Healthcare Company $23,270.46 06/13/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319207
Principal investigator 1 ViiV Healthcare Company $97,022.20 05/28/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317235
Principal investigator 1 ViiV Healthcare Company $12,970.04 05/19/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317175
Principal investigator 1 ViiV Healthcare Company $6,917.34 04/28/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190319213
Principal investigator 1 ViiV Healthcare Company $3,592.09 04/10/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317231
Principal investigator 1 ABBVIE INC. $2,076.64 04/03/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202472285
Principal investigator 1 ViiV Healthcare Company $6,052.71 03/21/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317173
Principal investigator 1 ViiV Healthcare Company $3,592.09 03/21/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317227
Principal investigator 1 ViiV Healthcare Company $2,733.14 03/21/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317233
Principal investigator 1 ABBVIE INC. $1,148.18 03/07/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202461314
Principal investigator 1 ViiV Healthcare Company $9,561.24 02/24/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190319211
Principal investigator 1 ABBVIE INC. $1,722.27 02/06/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202448798
Principal investigator 1 ViiV Healthcare Company $6,154.79 01/08/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317171
Principal investigator 1 ABBVIE INC. $1,814.74 01/02/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202435212